Learn about this type of arthritis that affects children and can cause growth problems, joint damage and eye inflammation.
Update Date: 28.05.2026
Juvenile idiopathic arthritis (JIA) is the most common type of arthritis in children younger than age 16. JIA is called idiopathic because the cause is not known. It happens when the immune system becomes overactive and causes inflammation in the body.
JIA can cause persistent joint pain, swelling and stiffness. For some children, these symptoms may last only a few years. For others, they can continue for many years.
Certain types of JIA can lead to serious complications, including slowed growth, joint damage and inflammation in the eyes. Treatment aims to lessen pain and swelling, help joints work better and prevent long-term damage.
The most common signs and symptoms of juvenile idiopathic arthritis are:
JIA can affect one joint or many. The main types are oligoarticular, polyarticular and systemic. Oligoarticular JIA affects a few joints. Polyarticular JIA affects five or more joints. And systemic JIA affects the joints and also causes symptoms throughout the whole body, such as fever or a rash on the back, belly or chest. The type classification depends on your child's symptoms, how many joints are affected, and whether fever or rash are present.
Like other forms of arthritis, JIA often comes in cycles. There are times when symptoms get worse, called flare-ups. And there are times when symptoms improve.
It's important to see a healthcare professional early if your child has swollen or stiff joints. Waiting too long to start treatment can lead to joint damage, make the treatment less effective and cause other health issues.
With treatment, most children have periods when they have no symptoms and the disease is not active. In some children JIA goes away completely. No further treatment is needed. But for some, it may be a lifelong condition that requires treatment into adulthood.
Juvenile idiopathic arthritis happens when the body's immune system mistakenly attacks its own healthy cells and tissues. It's not known why this happens, but both inherited traits and environmental factors may play a role.
Some forms of juvenile idiopathic arthritis are more common in girls than in boys. The reason for this is not fully understood. But researchers believe it may be linked to differences in hormones and the immune system. Genetics also may play a role, as certain inherited traits can make a child more likely to develop JIA.
Juvenile idiopathic arthritis can lead to serious health conditions. Watching your child's symptoms closely and getting regular medical care helps lower the risk of these complications.
Diagnosing juvenile idiopathic arthritis can be challenging because many conditions can cause joint pain. There's no single test to confirm JIA, but certain tests can help rule out other conditions with similar symptoms.
Your child's healthcare professional typically asks about symptoms and when they began. You may be asked about your child's family medical history because autoimmune conditions like JIA can run in families. Your child's healthcare professional may look for signs of trouble walking, moving the neck, or raising or closing the hands. They may check your child's eyes to look for issues that come from inflammation.
Blood tests and imaging scans also can help diagnose JIA.
Common blood tests your child's healthcare professional may order include:
Many children with JIA have results in the standard range on these blood tests.
X-rays or MRI scans may be done to rule out other issues such as broken bones, tumors, infections or birth defects.
After diagnosis, imaging may be repeated from time to time to check how bones are growing and to look for signs of joint damage.
The main goal of treating juvenile idiopathic arthritis is to help your child stay active, take part in everyday life and avoid long-term health issues. Healthcare professionals often combine different treatments to:
Most children with JIA need a mix of medicines and healthy habits, such as a balanced diet and exercise, to reach these goals. The treatment plan depends on your child's age, the type of JIA they have, and how serious symptoms are.
Medicines are chosen to lessen pain, improve movement and lower the risk of lasting joint damage. Common options include:
Biologic agents. These newer drugs target the immune system in specific ways to lessen inflammation and protect joints. Also known as biologic response modifiers, they include tumor necrosis factor (TNF) blockers, such as etanercept (Enbrel, Erelzi, Eticovo), adalimumab (Humira), golimumab (Simponi) and infliximab (Remicade, Inflectra, others).
Other biologic agents include abatacept (Orencia), rituximab (Rituxan, Truxima, Ruxience), anakinra (Kineret) and tocilizumab (Actemra). They may be used with DMARDs and other medicines. All biologics raise the risk of infection.
In very serious cases, surgery may be needed to improve joint function or to treat cataracts.
Parents and caregivers can help children with JIA learn self-care habits that lessen symptoms and protect joint health. These include:
Family support plays an important role in helping children manage juvenile idiopathic arthritis. Parents can take these actions:
If your child's pediatrician or family healthcare professional suspects that your child has juvenile idiopathic arthritis, you may be referred to a doctor who specializes in arthritis, called a rheumatologist, for diagnosis and treatment planning.
Before the appointment, it can help to make a list that includes:
Your child's healthcare professional may ask questions such as:
© 2026 Mayo Foundation for Medical Education and Research. All rights reserved. Terms of Use